In simple terms
Bone marrow is the spongy tissue inside bones responsible for producing all blood cells. Certain cancers, and the high-dose treatments needed to fight them, can destroy this marrow. A stem cell transplant works like a cellular reboot. After intense chemotherapy clears away abnormal cells, doctors infuse healthy blood-forming stem cells into your bloodstream through a drip. These cells travel into your bones, take root, and rebuild a healthy blood and immune system. Depending on your situation, cells come from your own body or a compatible donor.
Key takeaways
- Replaces damaged or destroyed bone marrow with healthy blood-forming cells.
- Autologous transplants use the patient's cells; allogeneic transplants use donor cells.
- Permits the use of high-dose chemotherapy to eliminate stubborn cancer cells.
- Requires an intensive recovery period while the new stem cells engraft.
Definition
A haematopoietic stem cell transplant restores the body's ability to produce red blood cells, white blood cells, and platelets. The procedure begins with a conditioning regimen consisting of high-dose chemotherapy, occasionally combined with total body irradiation, aimed at eradicating residual cancer cells and clearing space within the marrow cavity.
Following conditioning, harvested haematopoietic stem cells are infused intravenously into the patient, where they migrate to the bone marrow niches and begin engraftment. Transplants are classified as autologous (using the patient's own pre-collected stem cells) or allogeneic (using cells from a matched related or unrelated donor, or umbilical cord blood).
Why it matters
A stem cell transplant enables doctors to administer higher, potentially curative doses of chemotherapy that would otherwise prove fatal to the bone marrow. In allogeneic transplantation, donor cells also generate a vital immunological benefit known as the 'graft-versus-tumor' effect, wherein the donor immune cells actively hunt down and destroy residual cancer cells, significantly lowering the risk of long-term disease recurrence.
Related biomarkers and tests
Before transplantation, patients undergo extensive organ function tests, disease reassessment scans, and infectious disease screenings. Allogeneic transplants require detailed human leukocyte antigen (HLA) tissue typing to match donor and recipient proteins. Post-transplant monitoring involves complete blood counts and chimerism assays to verify donor cell engraftment.
Related cancers
Stem cell transplants are primarily employed in haematological malignancies. These include multiple myeloma, Hodgkin and non-Hodgkin lymphomas, acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), myelodysplastic syndromes (MDS), and certain pediatric solid tumors, such as high-risk neuroblastoma.
Related treatments
Transplantation is integrated into broader multimodal protocols, serving as consolidation therapy after initial chemotherapy achieves remission. Allogeneic recipients require post-transplant immunosuppressive medications (such as cyclosporine or tacrolimus) to prevent graft-versus-host disease (GvHD). Prophylactic antimicrobial agents are administered during profound marrow suppression.
Frequently asked questions
What is the difference between an autologous and allogeneic transplant?
An autologous transplant uses your own stem cells, harvested and frozen before high-dose chemotherapy. An allogeneic transplant uses stem cells collected from a matched donor, which introduces a new immune system to help fight the underlying cancer.
What does engraftment mean?
Engraftment occurs when the infused stem cells successfully settle into the bone marrow and start producing normal, healthy white blood cells, red blood cells, and platelets. This process typically takes between two and four weeks.
What is graft-versus-host disease (GvHD)?
Graft-versus-host disease is a complication unique to allogeneic transplants, where the donor's immune cells recognise the recipient's normal tissues as foreign and mount an inflammatory attack, commonly affecting the skin, liver, and digestive tract.
References
- 1.Stem Cell Transplants in Cancer Treatment— National Cancer Institute
- 2.What is a Bone Marrow Transplant (Stem Cell Transplant)?— American Society of Clinical Oncology
- 3.Haematopoietic Stem Cell Transplantation Guidelines— European Society for Medical Oncology
Ask GetOnco AI
Get personalised answers about Stem Cell Transplant — Bone Marrow Restoration from your AI cancer care coordinator.
- Can you explain Stem Cell Transplant — Bone Marrow Restoration in simple words?
- What does Stem Cell Transplant — Bone Marrow Restoration mean for my treatment plan?
- What questions should I ask my oncologist about Stem Cell Transplant — Bone Marrow Restoration?
- What next steps do you recommend regarding Stem Cell Transplant — Bone Marrow Restoration?
GetOnco AI provides educational information and never replaces advice from your medical team.
Explore related topics
Related treatments
Related reading
More in this section
Glossary terms in this article
Last reviewed August 1, 2026
Medical disclaimer
Educational information only. GetOnco is software, not a medical provider, and does not diagnose disease or recommend treatments. Always discuss your situation with qualified healthcare professionals.